Influence of Dose Intensity in Consolidation with HIDAC and Other Clinical and Biological Parameters in the Survival of AML.
Ricardo Ballesteros-RamírezSandra QuijanoJulio SolanoCamila Ordoñez-ReyesMaría V HerreraRául MurilloSusana FiorentinoMónica Arevalo-ZambranoPublished in: Journal of cancer epidemiology (2020)
This retrospective study allowed us to know the epidemiology of AML in a reference Colombian Hospital. Additionally, in our knowledge, it is the first study that reports the RDI in consolidation with HIDAC in Latin America as a prognostic factor that directly impacts the OS.